MULTIPLE MYELOMA OF BONE

Clinical trials for MULTIPLE MYELOMA OF BONE explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA OF BONE trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested for Tough-to-Treat blood cancer

Disease control Ongoing

This is an early-stage study to test the safety of a new drug called HPN217 (or MK-4002) for people with multiple myeloma that has come back or stopped responding to other treatments. Researchers will give increasing doses to about 100 participants to find the highest dose that i…

Matched conditions: MULTIPLE MYELOMA OF BONE

Phase: PHASE1 • Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

MULTIPLE MYELOMA OF BONE

Get alerted when new MULTIPLE MYELOMA OF BONE trials appear

New drug tested for Tough-to-Treat blood cancer